People will believe a big lie sooner than a little one, and if you repeat it frequently enough, people will sooner or later believe it.
On November 19, 2025, the New England Journal of Medicine published an article entitled “Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.” This article purportedly reviewed the results of Pfizer’s Phase 3 clinical trials testing its experimental, mRNA-based, gene therapy injections for Influenza, which Pfizer presents as an alternative to traditional Influenza vaccines.
Two weeks later, on December 5, 2025, the Centers for Disease Control’s Advisory Committee on Immunization Practices (ACIP) voted 8-3 to end the recommendation in the CDC’s pediatric vaccine schedule that all American children receive the Hepatitis B Virus (HBV) vaccine at birth. This recommendation would bring the CDC’s HBV vaccine recommendations closer to those in numerous other developed nations, countries that have both better overall pediatric health than the United States and no surplus pediatric HBV deaths.